We are live on ! Find out more
ACM

Apex Capital Management Portfolio holdings

AUM $4.54B
1-Year Est. Return 1.74%
This Fund
S&P 500
This Quarter Est. Return
-1.95%
1 Year Est. Return
+1.74%
3 Year Est. Return
+80.63%
5 Year Est. Return
10 Year Est. Return
AUM
$4.54B
AUM Growth
+$63M
Cap. Flow
+$255M
Cap. Flow %
5.63%
Top 10 Hldgs %
17.96%
Holding
270
New
24
Increased
161
Reduced
65
Closed
7

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.14%
2 Technology 19.48%
3 Industrials 18.87%
4 Healthcare 18.09%
5 Financials 5.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDXX icon
51
Idexx Laboratories
IDXX
$44.8B
$40M 0.88%
510,565
+15,756
+3% +$1.13M
IBKR icon
52
Interactive Brokers
IBKR
$40.3B
$39.9M 0.88%
4,055,680
+253,276
+7% +$2.24M
DLB icon
53
Dolby
DLB
$4.64B
$38.1M 0.84%
876,285
+19,213
+2% +$713K
ENTA icon
54
Enanta Pharmaceuticals
ENTA
$400M
$38M 0.84%
1,292,751
+82,294
+7% +$2.29M
ENTG icon
55
Entegris
ENTG
$21.1B
$36.3M 0.8%
2,667,493
+18,064
+0.7% +$219K
BR icon
56
Broadridge
BR
$17.3B
$35.9M 0.79%
+604,748
New +$33M
DATA
57
DELISTED
Tableau Software, Inc.
DATA
$35.8M 0.79%
780,073
+11,845
+2% +$687K
ACIW icon
58
ACI Worldwide
ACIW
$5.9B
$35.3M 0.78%
1,699,931
+39,329
+2% +$740K
DNKN
59
DELISTED
Dunkin' Brands Group, Inc.
DNKN
$34.8M 0.77%
738,177
+27,164
+4% +$1.17M
EEFT icon
60
Euronet Worldwide
EEFT
$3.1B
$31.4M 0.69%
423,371
+68,131
+19% +$4.81M
HZNP
61
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$30.9M 0.68%
1,867,677
+156,588
+9% +$2.74M
VRNT
62
DELISTED
Verint Systems
VRNT
$30.3M 0.67%
1,780,158
+151,781
+9% +$2.77M
KS
63
DELISTED
KapStone Paper and Pack Corp.
KS
$30M 0.66%
2,162,867
+118,477
+6% +$1.6M
ISEE
64
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$28.7M 0.63%
678,284
+49,641
+8% +$2.53M
CLB icon
65
Core Laboratories
CLB
$523M
$26.7M 0.59%
237,242
+6,351
+3% +$660K
ABMD
66
DELISTED
Abiomed Inc
ABMD
$26.4M 0.58%
278,326
+44,570
+19% +$3.76M
DDS icon
67
Dillards
DDS
$8.6B
$26.1M 0.57%
306,960
+8,741
+3% +$655K
BEAV
68
DELISTED
B/E Aerospace Inc
BEAV
$24.6M 0.54%
533,801
+16,944
+3% +$725K
SUPN icon
69
Supernus Pharmaceuticals
SUPN
$2.79B
$22.6M 0.5%
1,483,104
+58,678
+4% +$766K
UTHR icon
70
United Therapeutics
UTHR
$22.7B
$22.3M 0.49%
199,892
+2,498
+1% +$316K
VEEV icon
71
Veeva Systems
VEEV
$31.7B
$22.2M 0.49%
886,488
+52,126
+6% +$1.28M
CRL icon
72
Charles River Laboratories
CRL
$10.8B
$21.4M 0.47%
281,742
+45,622
+19% +$3.38M
GWRE icon
73
Guidewire Software
GWRE
$12.5B
$19M 0.42%
348,809
+5,897
+2% +$308K
WWAV
74
DELISTED
The WhiteWave Foods Company
WWAV
$19M 0.42%
+466,985
New +$17.7M
MNTA
75
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$17.9M 0.39%
1,937,344
+827,272
+75% +$8.9M

Similar funds

Apex Capital Management's Q1 2016 Portfolio in Review

As of Q1 2016, Apex Capital Management held 270 positions worth $4.54B, up 1.4% from $4.47B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Apex Capital Management deployed $255M of net new capital in Q1 2016, opening 24 new positions and adding to 161 existing holdings. Its largest new stake was Willis Towers Watson: 462,728 shares worth $54.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was HEARTLAND PAYMENT SYSTEMS, INC. COM STK, an estimated $39.8M trimmed.

  • Apex Capital Management's largest Q1 2016 buy was Willis Towers Watson: 462,728 shares worth $54.9M.
  • Apex Capital Management added most to BroadSoft, Inc. in Q1 2016, an estimated $14.9M increase.
  • Apex Capital Management's biggest Q1 2016 reduction was HEARTLAND PAYMENT SYSTEMS, INC. COM STK, cutting an estimated $39.8M.
  • Apex Capital Management fully exited Global Payments in Q1 2016, selling an estimated $92M.
  • Apex Capital Management's ten largest holdings make up 18% of its $4.54B portfolio in Q1 2016.
  • Apex Capital Management opened 24 new positions and closed 7 in Q1 2016.
  • Apex Capital Management's portfolio value rose 1.4% quarter-over-quarter to $4.54B.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.